title: Toxic epidermal necrolysis induced by ofloxacin.
authors.forename: Sun-Young
authors.initials: SY
authors.lastname: Yoon
authors.forename: Yun-Jeong
authors.initials: YJ
authors.lastname: Bae
authors.forename: You Sook
authors.initials: YS
authors.lastname: Cho
authors.forename: Hee-Bom
authors.initials: HB
authors.lastname: Moon
authors.forename: Tae-Bum
authors.initials: TB
authors.lastname: Kim
mesh_terms: D000284:Administration, Oral; D000305:Adrenal Cortex Hormones / Q000008:administration & dosage; D000328:Adult; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000009:adverse effects*; D001458:Bandages; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000008:administration & dosage; D015242:Ofloxacin / Q000008:administration & dosage / Q000009:adverse effects*; D010288:Parenteral Nutrition; D013262:Stevens-Johnson Syndrome / Q000209:etiology* / Q000473:pathology / Q000628:therapy; D016896:Treatment Outcome
chemical_list: D000305:Adrenal Cortex Hormones; D000900:Anti-Bacterial Agents; D016756:Immunoglobulins, Intravenous; D015242:Ofloxacin